| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1000266809 |
| P356 | DOI | 10.1038/NRN3900 |
| P698 | PubMed publication ID | 25697158 |
| P5875 | ResearchGate publication ID | 272517770 |
| P50 | author | Roland Martin | Q69171707 |
| P2093 | author name string | Richard Reynolds | |
| Massimiliano Calabrese | |||
| Jeroen J G Geurts | |||
| Olga Ciccarelli | |||
| Roberta Magliozzi | |||
| P2860 | cites work | Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis | Q24635370 |
| White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis | Q24642079 | ||
| Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain | Q24642187 | ||
| Mitochondrial defects in acute multiple sclerosis lesions | Q24648580 | ||
| Recognition of conserved amino acid motifs of common viruses and its role in autoimmunity | Q24812119 | ||
| Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo | Q27860578 | ||
| Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis | Q28252596 | ||
| Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion | Q28253124 | ||
| Elevated matrix metalloproteinase-9 and degradation of perineuronal nets in cerebrocortical multiple sclerosis plaques | Q28291397 | ||
| The immunopathology of multiple sclerosis: an overview | Q28295115 | ||
| Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord | Q28295737 | ||
| The blood-brain barrier in cortical multiple sclerosis lesions | Q28296839 | ||
| Epstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosis | Q28731829 | ||
| Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis | Q28943414 | ||
| Spinal cord neuronal pathology in multiple sclerosis | Q48787320 | ||
| Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions | Q48789208 | ||
| Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions | Q48791086 | ||
| The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction | Q48851450 | ||
| Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL. | Q48894792 | ||
| Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis | Q48949792 | ||
| Gray and white matter volume changes in early RRMS: a 2-year longitudinal study. | Q48958924 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis. | Q51666856 | ||
| Brain atrophy in clinically early relapsing-remitting multiple sclerosis. | Q52046432 | ||
| Multiple sclerosis and Epstein-Barr virus | Q56765366 | ||
| Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis — A longitudinal voxel-based morphometry study | Q57260193 | ||
| Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability | Q57655312 | ||
| A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes | Q57911812 | ||
| T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis | Q59049915 | ||
| Altered Glutamate Reuptake in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis Cortex: Correlation With Microglia Infiltration, Demyelination, and Neuronal and Synaptic Damage | Q61478748 | ||
| Cortical lesions in multiple sclerosis | Q63185098 | ||
| Histocompatibility determinants in multiple sclerosis, with special reference to clinical course | Q70004581 | ||
| Extensive hippocampal demyelination in multiple sclerosis | Q81098501 | ||
| The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions | Q81485093 | ||
| Immunology of multiple sclerosis | Q81531267 | ||
| A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis | Q83729196 | ||
| Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis | Q84077539 | ||
| Magnetic resonance evidence of cortical onset of multiple sclerosis | Q48489792 | ||
| Different white matter lesion characteristics correlate with distinct grey matter abnormalities on magnetic resonance imaging in secondary progressive multiple sclerosis | Q48618954 | ||
| Increased Meningeal T and Plasma Cell Infiltration is Associated with Early Subpial Cortical Demyelination in Common Marmosets with Experimental Autoimmune Encephalomyelitis. | Q48650442 | ||
| Cortical demyelination and diffuse white matter injury in multiple sclerosis. | Q48726181 | ||
| Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway | Q48759132 | ||
| Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? | Q29042454 | ||
| Multiple sclerosis | Q29616022 | ||
| Microglia: a sensor for pathological events in the CNS | Q29620556 | ||
| Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. | Q30758003 | ||
| What explains gray matter atrophy in long-standing multiple sclerosis? | Q30807961 | ||
| Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis | Q33211732 | ||
| Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging | Q33406724 | ||
| Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis | Q33418162 | ||
| Cortical lesions in multiple sclerosis | Q33631075 | ||
| Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis | Q33834491 | ||
| Multiple sclerosis: distribution of inflammatory cells in newly forming lesions | Q34089994 | ||
| Immune function of microglia | Q34094707 | ||
| Epstein-barr virus infection and multiple sclerosis: a review | Q34108508 | ||
| The neuropathological basis of clinical progression in multiple sclerosis | Q34188436 | ||
| Cortical lesions in radiologically isolated syndrome. | Q34231830 | ||
| Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis | Q34295012 | ||
| Mycovirus-like DNA virus sequences from cattle serum and human brain and serum samples from multiple sclerosis patients | Q34435808 | ||
| Widespread demyelination in the cerebellar cortex in multiple sclerosis. | Q34627051 | ||
| Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis | Q34671815 | ||
| Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection | Q34721399 | ||
| Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients. | Q34733726 | ||
| Reciprocal interactions between microglia and neurons: from survival to neuropathology | Q34982917 | ||
| Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. | Q34986741 | ||
| Disability, atrophy and cortical reorganization following spinal cord injury | Q35007867 | ||
| High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells | Q35221540 | ||
| Granzyme A released upon stimulation of cytotoxic T lymphocytes activates the thrombin receptor on neuronal cells and astrocytes | Q35682957 | ||
| Inflammatory cortical demyelination in early multiple sclerosis | Q35764685 | ||
| NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury | Q35776944 | ||
| Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation | Q36174679 | ||
| Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain | Q36229219 | ||
| Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction | Q36368672 | ||
| Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. | Q36370963 | ||
| Induction of MHC class I genes in neurons | Q36688665 | ||
| Pathogenesis of axonal and neuronal damage in multiple sclerosis | Q36840382 | ||
| Disease-specific molecular events in cortical multiple sclerosis lesions. | Q36904909 | ||
| MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis | Q36904914 | ||
| Chronic microglial activation and progressive dopaminergic neurotoxicity. | Q36979645 | ||
| Mitochondrial DNA repair in aging and disease | Q37140173 | ||
| In vivo evidence of disseminated subpial T2* signal changes in multiple sclerosis at 7 T: a surface-based analysis | Q37296089 | ||
| Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis | Q37398059 | ||
| Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? | Q37767300 | ||
| Will the real multiple sclerosis please stand up? | Q38020092 | ||
| The role of mitochondria in axonal degeneration and tissue repair in MS. | Q38020826 | ||
| Progressive multiple sclerosis: pathology and pathogenesis | Q38046113 | ||
| Neurons as targets for T cells in the nervous system. | Q38088075 | ||
| Environmental factors in multiple sclerosis | Q38167388 | ||
| Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria. | Q38366750 | ||
| Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis | Q38473043 | ||
| Cytotoxic NKG2C+ CD4 T cells target oligodendrocytes in multiple sclerosis. | Q39196922 | ||
| The significance of perivascular infiltrations in multiple sclerosis | Q39372080 | ||
| The distribution of plaques in the cerebrum in multiple sclerosis | Q39412145 | ||
| Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis. | Q40581562 | ||
| Low prevalence of TT virus in the cerebrospinal fluid of viremic patients with central nervous system disorders | Q42658581 | ||
| A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. | Q42847184 | ||
| Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. | Q43241664 | ||
| The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis | Q43426688 | ||
| Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study | Q45304939 | ||
| Radioactive in situ hybridization for Epstein-Barr virus-encoded small RNA supports presence of Epstein-Barr virus in the multiple sclerosis brain | Q45352914 | ||
| B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis | Q45353475 | ||
| Detection of Epstein-Barr virus and B-cell follicles in the multiple sclerosis brain: what you find depends on how and where you look | Q45373480 | ||
| MHC class I-restricted killing of neurons by virus-specific CD8+ T lymphocytes is effected through the Fas/FasL, but not the perforin pathway,. | Q45738816 | ||
| Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats | Q45799560 | ||
| Connecting white matter injury and thalamic atrophy in clinically isolated syndromes. | Q46023385 | ||
| The changing clinical course of multiple sclerosis: a matter of gray matter | Q46292409 | ||
| Interferon-gamma directly induces neurotoxicity through a neuron specific, calcium-permeable complex of IFN-gamma receptor and AMPA GluR1 receptor | Q46806149 | ||
| Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. | Q47357498 | ||
| Focal thinning of the cerebral cortex in multiple sclerosis | Q47835048 | ||
| Evidence of early cortical atrophy in MS: relevance to white matter changes and disability | Q47983445 | ||
| Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords | Q48099284 | ||
| Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. | Q48200750 | ||
| Subpial demyelination in the cerebral cortex of multiple sclerosis patients | Q48233815 | ||
| Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis | Q48236822 | ||
| Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional grey matter volume reductions in relapsing-remitting multiple sclerosis | Q48330322 | ||
| Localization of grey matter atrophy in early RRMS : A longitudinal study | Q48375268 | ||
| Heterogeneity of cortical lesions in multiple sclerosis: clinical and pathologic implications | Q48379680 | ||
| Cytotoxic CD8+ T cell-neuron interactions: perforin-dependent electrical silencing precedes but is not causally linked to neuronal cell death | Q48380024 | ||
| Neocortical neuronal, synaptic, and glial loss in multiple sclerosis | Q48413281 | ||
| Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis | Q48485900 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple sclerosis | Q8277 |
| P304 | page(s) | 147-158 | |
| P577 | publication date | 2015-03-01 | |
| P1433 | published in | Nature Reviews Neuroscience | Q2108225 |
| P1476 | title | Exploring the origins of grey matter damage in multiple sclerosis | |
| P478 | volume | 16 |
| Q52098372 | A "kissing lesion": In-vivo 7T evidence of meningeal inflammation in early multiple sclerosis. |
| Q39314274 | A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause? |
| Q92192321 | A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward |
| Q37149926 | A large fraction of neocortical myelin ensheathes axons of local inhibitory neurons |
| Q30825494 | Advanced MRI and staging of multiple sclerosis lesions |
| Q38631344 | Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy |
| Q89957895 | Alterations in functional connectivity are associated with white matter lesions and information processing efficiency in multiple sclerosis |
| Q34547552 | An updated histological classification system for multiple sclerosis lesions |
| Q41686940 | Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis. |
| Q36138217 | Astrocyte matricellular proteins that control excitatory synaptogenesis are regulated by inflammatory cytokines and correlate with paralysis severity during experimental autoimmune encephalomyelitis |
| Q37729235 | Autophagy and Microglia: Novel Partners in Neurodegeneration and Aging. |
| Q49962896 | Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945. |
| Q36089786 | Cell death of spinal cord ED1(+) cells in a rat model of multiple sclerosis. |
| Q31009955 | Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex. |
| Q40338918 | Changes in brain functional connectivity patterns are driven by an individual lesion in MS: a resting-state fMRI study |
| Q55397967 | Clinical significance of cortical lesions in patients with multiple sclerosis: A neuropsychological and neuroimaging study. |
| Q45032169 | Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact |
| Q39374093 | Control of immune-mediated pathology via the aryl hydrocarbon receptor |
| Q52145478 | Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant. |
| Q36357501 | Defining Disease Activity and Response to Therapy in MS. |
| Q64110821 | Development of Cortical Lesion Volumes on Double Inversion Recovery MRI in Patients With Relapse-Onset Multiple Sclerosis |
| Q55009229 | Dorsal and ventral horn atrophy is associated with clinical outcome after spinal cord injury. |
| Q59133133 | Early auto-immune targeting of photoreceptor ribbon synapses in mouse models of multiple sclerosis |
| Q89999379 | Epidemiology and treatment of multiple sclerosis in elderly populations |
| Q36283207 | Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis |
| Q58573154 | Functional Connectivity in Multiple Sclerosis: Recent Findings and Future Directions |
| Q92427702 | Gray Matter Alterations in Early and Late Relapsing-Remitting Multiple Sclerosis Evaluated with Synthetic Quantitative Magnetic Resonance Imaging |
| Q102074553 | Gray and white matter are both affected in classical galactosemia: An explorative study on the association between neuroimaging and clinical outcome |
| Q45841514 | Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest |
| Q92244105 | Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study |
| Q48257014 | Grey:white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression |
| Q48276487 | Heterogeneity of Cortical Lesion Susceptibility Mapping in Multiple Sclerosis. |
| Q41476817 | Hyperpolarized 13C MR metabolic imaging can detect neuroinflammation in vivo in a multiple sclerosis murine model |
| Q35838665 | Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial |
| Q89434252 | Impact of Focal White Matter Damage on Localized Subcortical Gray Matter Atrophy in Multiple Sclerosis: A 5-Year Study |
| Q48017244 | Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis |
| Q92286167 | Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15 |
| Q37655201 | Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study. |
| Q53090981 | Increased structural white and grey matter network connectivity compensates for functional decline in early multiple sclerosis. |
| Q49832443 | Journal Club: MRI reveals acute inflammation in cortical lesions during early MS. |
| Q37587696 | Leptin sustains spontaneous remyelination in the adult central nervous system. |
| Q64095794 | Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis |
| Q64266133 | MRI phenotypes in MS: Longitudinal changes and miRNA signatures |
| Q89938771 | Magnetic Resonance Imaging in Multiple Sclerosis |
| Q38794193 | Management of neurogenic bladder in patients with multiple sclerosis |
| Q91763674 | Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis |
| Q55561652 | Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis. |
| Q64066497 | Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers |
| Q47144073 | Monitoring disease activity in multiple sclerosis using serum neurofilament light protein |
| Q88652491 | Much, if not all, of the cortical damage in MS can be attributed to the microglial cell - No |
| Q91210808 | Multiple sclerosis and cognition: synaptic failure and network dysfunction |
| Q62675748 | Myalgic encephalomyelitis or chronic fatigue syndrome: how could the illness develop? |
| Q100385821 | Myelin replacement triggered by single-cell demyelination in mouse cortex |
| Q41510304 | Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology? |
| Q41170163 | Neurodegeneration in multiple sclerosis is a process separate from inflammation: No. |
| Q47623982 | Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis. |
| Q38931740 | Neuronal loss, demyelination and volume change in the multiple sclerosis neocortex |
| Q30943783 | Newer multiple sclerosis drugs and disability scores-are key data analyses missing? |
| Q39263834 | Outdoor Ambient Air Pollution and Neurodegenerative Diseases: the Neuroinflammation Hypothesis |
| Q64029447 | Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis |
| Q53212006 | Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod. |
| Q33365606 | Primary Progressive Multiple Sclerosis: Putting Together the Puzzle |
| Q29030703 | Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives |
| Q91770407 | Proceedings from the Albert Charitable Trust Inaugural Workshop on white matter and cognition in aging |
| Q90308026 | Prognostic value of white matter lesion shrinking in early multiple sclerosis: An intuitive or naïve notion? |
| Q55362467 | Progression of regional grey matter atrophy in multiple sclerosis. |
| Q90406416 | Progressive brain rich-club network disruption from clinically isolated syndrome towards multiple sclerosis |
| Q47755455 | Prospective memory impairment in multiple sclerosis: a review |
| Q88621751 | Protective potential of dimethyl fumarate in a mouse model of thalamocortical demyelination |
| Q39332179 | Re-imagining Alzheimer's disease - the diminishing importance of amyloid and a glimpse of what lies ahead. |
| Q34505106 | Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis |
| Q37451021 | Relationships between cortical myeloarchitecture and electrophysiological networks |
| Q39057292 | Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis |
| Q92296467 | Saltatory Conduction along Myelinated Axons Involves a Periaxonal Nanocircuit |
| Q92205966 | Second language learning induces grey matter volume increase in people with multiple sclerosis |
| Q50225781 | Sex differences and subclinical retinal injury in pediatric-onset MS. |
| Q39448667 | Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis |
| Q91842191 | Siponimod therapy implicates Th17 cells in a preclinical model of subpial cortical injury |
| Q91137193 | Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders |
| Q38737202 | Spring cleaning: time to rethink imaging research lines in MS? |
| Q39029925 | Stable spline deconvolution for dynamic susceptibility contrast MRI. |
| Q39145827 | Stromal Cell Niches in the Inflamed Central Nervous System |
| Q38639337 | Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis. |
| Q48127262 | Thalamus Degeneration and Inflammation in Two Distinct Multiple Sclerosis Animal Models |
| Q37048758 | The Contribution of Cortical Lesions to a Composite MRI Scale of Disease Severity in Multiple Sclerosis |
| Q37411407 | The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T2* mapping at 7 T MRI. |
| Q89228120 | The effect of fingolimod on focal and diffuse grey matter damage in active MS patients |
| Q36171258 | The relevance of cortical lesions in patients with multiple sclerosis |
| Q47579410 | The role of blood and CSF biomarkers in the evaluation of new treatments against multiple sclerosis |
| Q47401912 | Therapeutic potential of curcumin for multiple sclerosis. |
| Q58775742 | Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis |
| Q41545569 | Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis |
| Q55115006 | Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation. |
| Q91943109 | Viral infections and multiple sclerosis |
| Q101405404 | Voxel-Based quantitative MRI reveals spatial patterns of grey matter alteration in multiple sclerosis |
| Q49021524 | What lies beneath grey matter atrophy in multiple sclerosis? |
| Q91763055 | β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration |
Search more.